Recent research focusing on Retatrutide at a dosage of 40mg is shedding new light on its potential benefits. Initial findings suggest that this higher dosage may boost the drug's ability to manage blood glucose, potentially offering greater outcomes for individuals with diabetes. Further research is underway to fully evaluate the long-term efficacy